CBER research update
Executive Summary
FDA's Biological Response Modifiers Advisory Committee will meet June 9 by teleconference to hear updates on research projects being conducted in the Center for Biologics Evaluation & Research's Division of Cellular & Gene Therapies. The meeting will be held from 1 p.m. to 3:30 p.m. and an audio link to the meeting will be available at the National Institutes of Health campus (building 29, room 1A09) in Bethesda, Md...